- Home
- SB vs LXRX Comparison
SB vs LXRX Comparison
Compare SB & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SB | LXRX |
|---|---|---|
| Founded | 2007 | 1995 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 591.5M | 703.3M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | SB | LXRX |
|---|---|---|
| Price | $6.67 | $1.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $6.00 | $4.15 |
| AVG Volume (30 Days) | 364.6K | ★ 1.8M |
| Earning Date | 05-18-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | $3.47 | N/A |
| Revenue Next Year | $3.61 | N/A |
| P/E Ratio | $16.77 | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $3.33 | $0.51 |
| 52 Week High | $6.78 | $1.95 |
Technical Indicators
Market Signals| Indicator | SB | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 56.82 | 46.60 |
| Support Level | $6.43 | $1.47 |
| Resistance Level | $6.71 | $1.65 |
| Average True Range (ATR) | 0.17 | 0.10 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 67.14 | 21.25 |
Price Performance
Historical ComparisonAbout SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.